Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores.

PURPOSE We assessed the complication rate of ultrasound guided prostate biopsies performed at a single center in a screening population. Moreover the impact of different biopsy protocols comprising varying numbers of biopsy cores on the complication rate was evaluated. MATERIALS AND METHODS A total of 5957 biopsies performed in 4303 clinically healthy men between January 1993 and August 2002 was evaluated retrospectively. Due to changes in the biopsy protocol, the number of biopsies obtained increased with time from 6 cores (January 1993 to October 1995) to 10 (November 1995 to March 2000) to 15 cores (March 2000 to August 2002). RESULTS Minor complications such as hematospermia (36.3%), hematuria (14.5%) and rectal bleeding persisting for up to 2 days (2.3%) were noted frequently, while major complications requiring further treatment were far less common. Post-biopsy fever was seen in 48 patients (0.8%), rectal bleeding requiring surgical intervention or persisting for more than 2 days occurred in 36 patients (0.6%) and urinary retention was observed in 12 patients (0.2%). The increase in biopsy cores with time did not result in increased post-biopsy morbidity. Prostate cancer at biopsy was not associated with a higher complication rate. CONCLUSIONS Prostate specific antigen screening has led to an increase in the number of patients undergoing prostate biopsy which, in turn, has increased the incidence of post-biopsy complications. However, most of the complications are minor and self-limiting. In this large study population the increased number of biopsy cores did not result in an increased incidence of major post-biopsy complications.

[1]  G. Bartsch,et al.  Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. , 2003, Urology.

[2]  F. Schröder,et al.  Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. , 1997, Urology.

[3]  M. Wirth,et al.  Morbidity and Discomfort of Ten-Core Biopsy of the Prostate Evaluated by Questionnaire , 2001, Urologia Internationalis.

[4]  J. Falcó,et al.  Massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. , 2000, Endoscopy.

[5]  I. Bozkirli,et al.  Antibiotic Prophylaxis for Transrectal Biopsy of the Prostate: A Prospective Randomized Study of the Prophylactic Use of Single Dose Oral Fluoroquinolone Versus Trimethoprim-Sulfamethoxazole , 2004, International Urology and Nephrology.

[6]  E. Canby-Hagino,et al.  Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. , 2002, The Journal of urology.

[7]  U. Norming,et al.  Complications following combined transrectal aspiration and core biopsy of the prostate. , 1990, Scandinavian journal of urology and nephrology.

[8]  E. Varenhorst,et al.  Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. , 1997, British journal of urology.

[9]  M. Perry,et al.  Pain after transrectal ultrasonography‐guided prostate biopsy: the advantages of periprostatic local anaesthesia , 2001, BJU international.

[10]  Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. , 2002 .

[11]  C. Obek,et al.  Is periprostatic local anesthesia for transrectal ultrasound guided prostate biopsy associated with increased infectious or hemorrhagic complications? A prospective randomized trial. , 2002, The Journal of urology.

[12]  C. Lee-Elliott,et al.  Randomized trial of lidocaine vs lidocaine/bupivacaine periprostatic injection on longitudinal pain scores after prostate biopsy. , 2004, The Journal of urology.

[13]  J. Hugosson,et al.  Transrectal ultrasound examination of the prostate: complications and acceptance by patients. , 1993, British journal of urology.

[14]  F. Sofras,et al.  Multiple Transrectal Ultrasound Guided Prostatic Biopsies: Morbidity and Tolerance , 2004, International Urology and Nephrology.

[15]  M. Peyromaure,et al.  Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. , 2002, The Journal of urology.

[16]  A. Zlotta,et al.  Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. , 2001, The Journal of urology.

[17]  V. Re,et al.  Gram-negative bacteremia after transrectal needle biopsy of the prostate. , 1980 .

[18]  M. Roobol,et al.  Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. , 2002, Urology.

[19]  D. Buskila,et al.  Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. , 1999, The Journal of infection.

[20]  M. Toublanc,et al.  Extensive biopsy protocol improves the detection rate of prostate cancer. , 2000, The Journal of urology.

[21]  K. Ghani,et al.  Bleeding after transrectal ultrasonography‐guided prostate biopsy: a study of 7‐day morbidity after a six‐, eight‐ and 12‐core biopsy protocol , 2004, BJU international.

[22]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.

[23]  H. Klocker,et al.  Prostate carcinoma screening in the county of Tyrol, Austria , 1997, Cancer.